Wuhan Healthgen Biotechnology Corp. (SHA:688765)
25.67
-1.60 (-5.87%)
At close: Nov 20, 2026
SHA:688765 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -138.17 | -157.04 | -151.37 | -186.96 | -143.58 | -134.04 |
Depreciation & Amortization | 68.92 | 65.57 | 61.44 | 47.82 | 12.92 | 10.04 |
Other Amortization | 0.73 | 0.72 | 0.4 | 0.01 | - | - |
Loss (Gain) From Sale of Assets | -2.64 | -3.79 | 1.28 | -1.01 | -0.33 | 11.27 |
Asset Writedown & Restructuring Costs | 0.71 | 0.71 | 0.48 | 1.11 | 1.3 | - |
Loss (Gain) From Sale of Investments | -8.97 | -0.91 | - | - | - | - |
Provision & Write-off of Bad Debts | -0.31 | 0.02 | -0 | 0.01 | -0.05 | 0 |
Other Operating Activities | 6.19 | 7.63 | 5.19 | 0.99 | 0.34 | 0.8 |
Change in Accounts Receivable | -96.03 | -77.56 | -9.95 | 18.19 | -7.88 | -21.29 |
Change in Inventory | -166.55 | -73.34 | -14.29 | -10.06 | -13.15 | 0.86 |
Change in Accounts Payable | 147.98 | 86.51 | 32.2 | -16.26 | 60.82 | 26.57 |
Change in Other Net Operating Assets | 20.55 | 23.16 | 21.1 | 23.32 | 23.2 | 17.82 |
Operating Cash Flow | -167.58 | -128.32 | -53.53 | -122.85 | -66.4 | -87.97 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -602.77 | -538.06 | -166.84 | -101.59 | -358.29 | -175.47 |
Sale of Property, Plant & Equipment | - | - | 40.48 | - | 0.68 | - |
Investment in Securities | -510 | -1,311 | - | - | - | - |
Investing Cash Flow | -1,113 | -1,849 | -126.37 | -101.59 | -357.61 | -175.47 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Issued | - | 411.59 | 133.55 | 77.98 | 30.4 | 9.9 |
Total Debt Issued | 419.63 | 411.59 | 133.55 | 77.98 | 30.4 | 9.9 |
Long-Term Debt Repaid | - | -337.86 | -23.85 | -1 | -16.27 | -20.29 |
Lease Payments | -11.98 | -16.05 | -0.35 | - | - | -0.39 |
Total Debt Repaid | -661.65 | -337.86 | -23.85 | -1 | -16.27 | -20.29 |
Net Debt Issued (Repaid) | -242.02 | 73.73 | 109.7 | 76.98 | 14.13 | -10.39 |
Issuance of Common Stock | 2,457 | 2,457 | - | - | 556.32 | 367.31 |
Common Dividends Paid | -12.95 | -14.5 | -4.63 | -1.18 | -0.74 | -0.66 |
Other Financing Activities | -31.05 | -29.86 | -0.8 | -3.17 | -1.58 | - |
Financing Cash Flow | 2,171 | 2,486 | 104.28 | 72.64 | 568.12 | 356.26 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | -0 | -0.03 | 0.06 | 0.22 | 0.04 | -0.07 |
Net Cash Flow | 890.53 | 509.04 | -75.57 | -151.58 | 144.15 | 92.75 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -770.36 | -666.38 | -220.38 | -224.45 | -424.7 | -263.44 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -1441.94% | -1392.31% | -873.96% | -925.01% | -3169.45% | -1032.38% |
Free Cash Flow Per Share | -2.35 | -2.35 | -0.82 | -0.84 | -1.63 | -1.22 |
Levered Free Cash Flow | -323.9 | -1,638 | -101.54 | -222.43 | -387.25 | -136.64 |
Unlevered Free Cash Flow | -320.42 | -1,633 | -98.36 | -222.01 | -387.11 | -136.31 |
Free Cash Flow After Leases | -782.34 | -682.43 | -220.73 | -224.45 | -424.7 | -263.84 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Income Tax Paid | 2.74 | 1.1 | -1.59 | -27.87 | -44.15 | -1.72 |
Change in Working Capital | -94.04 | -41.23 | 29.05 | 15.19 | 62.99 | 23.95 |